EUVIMEDExplore EUVIMED
ÜbersichtsarbeitFallbericht

Surgery of enlarging lesions after stereotactic radiosurgery for brain metastases in patients with non‐small cell lung cancer with oncogenic driver mutations frequently reveals radiation necrosis: case series and review

Fang Zhou iD, Leilei Jiang, Xuankai Sun, Zhen Wang, Jialin Feng, Ming Liu, Zhao Ma

APMIS · 2024

DOI: 10.1111/apm.13402 ↗

At a glance

Übersichtsarbeit in APMIS, 2024. Written by Fang Zhou and 6 co-authors. Institution: Departments of Radiotherapy, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China. Major MEDLINE topics: Carcinoma, Non-Small-Cell Lung, Radiosurgery, Brain Neoplasms, Lung Neoplasms. 30 references.

AbstractSubjectsBibliographic detailsCiteRelated studies

Abstract (original language)

In brain metastases, radiation necrosis (RN) is a complication that arises after single or multiple fractionated stereotactic radiosurgery (SRS/FSRS), which is challenging to distinguish from local recurrence (LR). Studies have shown increased RN incidence rates in non‐small cell lung cancer (NSCLC) patients with oncogenic driver mutations (ODMs) or receiving tyrosine kinase inhibitors (TKIs). This study investigated enlarging brain lesions following SRS/FSRS, for which additional surgeries were performed to distinguish between RN and LR. We investigated seven NSCLC patients with ODMs undergoing SRS/FSRS for BM and undergoing surgery for suspicion of LR on MRI imaging. Descriptive statistics were performed. Among the seven patients, six were EGFR+, while one was ALK+. The median irradiation dose was 30 Gy (range, 20–35 Gy). The median time to develop RN after SRS/FSRS was 11.1 months (range: 6.3–31.2 months). Moreover, gradually enlarging lesions were found in all patients after 6 months post‐SRS/FSR. Brain radiation necrosis was pathologically confirmed in all the patients. RN should be suspected in NSCLC patients when lesions keep enlarging after 6 months post‐SRS/FSRS, especially for patients with ODMs and receiving TKIs. Further, this case series indicates that further dose reduction might be necessary to avoid RN for such patients.

Subjects

MeSH terms (MEDLINE)

Carcinoma, Non-Small-Cell LungRadiosurgeryBrain NeoplasmsLung NeoplasmsNecrosisMutationRadiation InjuriesHumansMiddle AgedMaleFemaleAgedMagnetic Resonance ImagingAdultBrainErbB Receptors

Author keywords

NSCLConcogenic driver mutationsradiation necrosisstereotactic radiosurgery

Substances

ErbB ReceptorsEGFR protein, human

Authors and institutions

  • Departments of Radiotherapy, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China.
  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital & Institute, Peking University, Beijing, China.

ORCID profiles: Fang Zhou

Cite

APA

Zhou, F., Jiang, L., Sun, X., Wang, Z., Feng, J., Liu, M., & Ma, Z. (2024). Surgery of enlarging lesions after stereotactic radiosurgery for brain metastases in patients with non‐small cell lung cancer with oncogenic driver mutations frequently reveals radiation necrosis: case series and review. APMIS. https://doi.org/10.1111/apm.13402

Vancouver

Zhou F, Jiang L, Sun X, Wang Z, Feng J, Liu M, et al. Surgery of enlarging lesions after stereotactic radiosurgery for brain metastases in patients with non‐small cell lung cancer with oncogenic driver mutations frequently reveals radiation necrosis: case series and review. APMIS. 2024. doi:10.1111/apm.13402

BibTeX
@article{Zhou2024,
  author = {Zhou, Fang and Jiang, Leilei and Sun, Xuankai and Wang, Zhen and Feng, Jialin and Liu, Ming and Ma, Zhao},
  title = {Surgery of enlarging lesions after stereotactic radiosurgery for brain metastases in patients with non‐small cell lung cancer with oncogenic driver mutations frequently reveals radiation necrosis: case series and review},
  journal = {APMIS},
  year = {2024},
  doi = {10.1111/apm.13402}
}
Start for free →